Efficacy evaluation of cosmetic formulations in conferring skin lightening in healthy human volunteers. - NI

ITC Life Sciences Technology Centre0 个研究点目标入组 100 人开始时间: 待定最近更新: 2022年10月17日

试验速览

暂无简介。

•1.Subject is willing to give a written informed consent
•2.Subject is a healthy adult female in the age range of 25 - 60 years
•3.At least 45 subjects in the age group of 40-48 yrs. (Perimenopausal phase) , 30 subjects in the age group of 49-60 yrs. (Menopausal phase).
•4.At least 30 subjects having a wrinkle score between 2 and 4 (moderate/ medium wrinkles) as per the photonumeric scale
•5.At least 30 women (mothers of 2-8yr old children) with post inflammatory hyperpigmentation marks on face (post acne / estrogen imbalance related marks). Subjects with mild melasma can be taken in the study.
•6.Subject who is willing to comply with the study protocol and abide by the study restrictions such as refraining from using cosmetic/ medicinal/ ayurvedic/ natural products on face and also willing to abstain from undergoing any facial treatments such as facial masks, packs, waxing, threading etc. either at home or at parlour other than the provided product during the entire study course.
•7.Subjects willing to visit the centre as per the specified schedule for regular follow up visits.
•8.Subjects willing to undergo UPT at the time of screening visit.

•1.Subject who is currently pregnant (as confirmed by the urine pregnancy test) or nursing or contemplating pregnancy (as disclosed voluntarily) during the study course.
•2.Subject with a known history or present condition of allergic response to any cosmetic products, toiletries or their ingredients including fragrance.
•3.Subject with a medical history of disease or condition or a concurrent illness or pre-existing or dormant dermatologic condition (psoriasis, rosacea, rashes, eczema etc.) that could interfere with the study results.
•4.Subject who has used any systemic medication (antibiotics, oral contraceptive pills, retinoids, steroids, spironolactone or any anti-acne medication) within past 4 weeks or any topical facial medication within 2 weeks before the start of the study, which could compromise the study.
•5.Subject has not participated in a similar clinical investigation in the past three months or applied skin lightening product on face or undergone a treatment like facial packs, bleaching in the past two weeks.
•6.Subject with excessive facial hair or scars, which could interfere with evaluation.
•7.Subject who shows no skin sensitivity symptoms to the investigational products during the skin sensitivity test.

发起方

ITC Life Sciences Technology Centre